The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma-Reference-Cited by-同舟云学术

The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma

Published:2009-03-01 Issue:5 Volume:115 Page:1028-1035
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Zorn Kristin K.,Tian Chunqiao,McGuire William P.,Hoskins William J.,Markman Maurie,Muggia Franco M.,Rose Peter G.,Ozols Robert F.,Spriggs David,Armstrong Deborah K.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference16 articles.

1. Reactivity of a monoclonal antibody with human ovarian carcinoma;Bast;J Clin Invest,1981

2. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16;Yin;J Biol Chem,2001

3. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer;Bast;N Engl J Med,1983

4. The CA 125 tumour-associated antigen: a review of the literature;Jacobs;Hum Reprod,1989

5. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N Engl J Med,1996

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Circulating Tumor DNA in Ovarian Cancer;Cancers;2024-09-10

2. Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer – An NRG/GOG study;Gynecologic Oncology;2024-02

3. HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial;Frontiers in Oncology;2024-01-11

4. Evaluating the Effectiveness of 2D and 3D CT Image Features for Predicting Tumor Response to Chemotherapy;Bioengineering;2023-11-20

5. Rare Epithelial Ovarian Cancers: Low Grade Serous and Mucinous Carcinomas;Cold Spring Harbor Perspectives in Medicine;2023-06-05